Venture capital fund formed to focus on dementia treatment startups

Illustration: Sarah Grillo/Axios Venture capital firm EQT Life Sciences yesterday announced the close of its debut LSP Dementia Fund, with €260 million in capital commitments. Why it matters: This is the first dementia-focused fund ever raised entirely by a European